Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells

Neuroscience Letters

Volumn 554, Issue , 2013, Pages 22-27

  Jeong, Sin Gu ^a   Ohn, Takbum ^a   Kim, Seung Hyun ^b   Cho, Goang Won ^a  

^a Chosun University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Bone marrow mesenchymal stem cells (BM MSCs); Histone deacetylase (HDAC); Mesenchymal stem cells (MSCs); Neuronal differentiation; Valproic acid (VPA)

Indexed keywords

CD133 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MUSASHI PROTEIN; NESTIN; NEUROFILAMENT M PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; POTASSIUM CHANNEL KCNH1; POTASSIUM CHANNEL KCNH5; PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; CELL FATE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESENCHYMAL STROMA CELL; NERVE CELL DIFFERENTIATION; NEURITE; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BHA; BM-MSCS; BONE MARROW-MESENCHYMAL STEM CELLS (BM-MSCS); BONE MARROW-MESENCHYMAL STROMAL CELLS; BUTYLATED HYDROXYANISOLE; CENTRAL NERVOUS SYSTEM; CNS; FBS; FETAL BOVINE SERUM; HDAC; HEMATOPOIETIC STEM CELLS; HISTONE DEACETYLASE; HISTONE DEACETYLASE (HDAC); HSC; MESENCHYMAL STEM CELLS (MSCS); MESENCHYMAL STROMAL CELLS; MSCS; NEURONAL DIFFERENTIATION; PBS; PCR; PHOSPHATE-BUFFERED SALINE; POLYMERASE CHAIN REACTION; REACTIVE OXYGEN SPECIES; ROOM TEMPERATURE; ROS; RT; VALPROIC ACID; VALPROIC ACID (VPA); VPA;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DENDRITES; HISTONE DEACETYLASE INHIBITORS; HUMANS; MESENCHYMAL STROMAL CELLS; NEURAL STEM CELLS; NEURONS; TRANSCRIPTOME; UP-REGULATION; VALPROIC ACID;

EID: 84884396891     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.059     Document Type: Article

References (32)

1. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
2. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
3. Chambers S.M., Shaw C.A., Gatza C., Fisk C.J., Donehower L.A., Goodell M.A. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007, 5:e201.
4. Cho G.W., Kang B.Y., Kim K.S., Kim S.H. Effects of valproic acid on the expression of trophic factors in human bone marrow mesenchymal stromal cells. Neurosci. Lett. 2012, 526:100-105.
5. Cho G.W., Noh M.Y., Kim H.Y., Koh S.H., Kim K.S., Kim S.H. Bone marrow-derived stromal cells from amyotrophic lateral sclerosis patients have diminished stem cell capacity. Stem Cells Dev. 2010, 19:1035-1042.
6. Dokmanovic M., Clarke C., Marks P.A. Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 2007, 5:981-989.
7. Fischle W., Wang Y., Allis C.D. Binary switches and modification cassettes in histone biology and beyond. Nature 2003, 425:475-479.
8. Gabbianelli M., Testa U., Massa A., Pelosi E., Sposi N.M., Riccioni R., Luchetti L., Peschle C. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood 2000, 95:3555-3561.
9. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Pelicci P.G., Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001, 20:6969-6978.
10. Gurvich N., Tsygankova O.M., Meinkoth J.L., Klein P.S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004, 64:1079-1086.
11. Haddad P.M., Das A., Ashfaq M., Wieck A. A review of valproate in psychiatric practice. Expert. Opin. Drug Metab. Toxicol. 2009, 5:539-551.
12. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. USA 2004, 101:16659-16664.
13. Iezzi S., Di Padova M., Serra C., Caretti G., Simone C., Maklan E., Minetti G., Zhao P., Hoffman E.P., Puri P.L., Sartorelli V. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell 2004, 6:673-684.
14. Iwata M., Muneoka K.T., Shirayama Y., Yamamoto A., Kawahara R. A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neurosci. Lett. 2005, 386:145-149.
15. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem. Int. 2000, 37:103-110.
16. Jonathan Ryves W., Dalton E.C., Harwood A.J., Williams R.S. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disord. 2005, 7:260-265.
17. Koch-Weser J., Browne T.R. Drug therapy: valproic acid. N. Engl. J. Med. 1980, 302:661-666.
18. Marianna P., Kollia P., Akel S., Papassotiriou Y., Stamoulakatou A., Loukopoulos D. Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures. Haematologica 2001, 86:700-705.
19. Minetti G.C., Colussi C., Adami R., Serra C., Mozzetta C., Parente V., Fortuni S., Straino S., Sampaolesi M., Di Padova M., Illi B., Gallinari P., Steinkuhler C., Capogrossi M.C., Sartorelli V., Bottinelli R., Gaetano C., Puri P.L. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 2006, 12:1147-1150.
20. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 2006, 6:38-51.
21. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276:36734-36741.
22. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
23. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 2004, 5:553-564.
24. Sengupta N., Seto E. Regulation of histone deacetylase activities. J. Cell Biochem. 2004, 93:57-67.
25. Shahien R., Saleh S.A., Bowirrat A. Intravenous sodium valproate aborts migraine headaches rapidly. Acta. Neurol. Scand. 2011, 123:257-265.
26. Smith A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 2001, 17:435-462.
27. Swank R.A., Skarpidi E., Papayannopoulou T., Stamatoyannopoulos G. The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced gamma globin expression in somatic cell hybrids and induces gamma gene expression in adult BFUe cultures. Blood Cells Mol. Dis. 2003, 30:254-257.
28. Thatava T., Ma B., Rohde M., Mayer H. Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells 2006, 24:2858-2867.
29. Van Zant G., Liang Y. The role of stem cells in aging. Exp. Hematol. 2003, 31:659-672.
30. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 2001, 17:387-403.
31. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000, 61:364-370.
32. Yu I.T., Park J.Y., Kim S.H., Lee J.S., Kim Y.S., Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009, 56:473-480.